Xeloda (Capecitabine)

Type
Product
Manufacturer
Country
Dosage
Qty
Price(USD)
Type: drug type
Product: Xeloda
Manufacturer: Hoffman - La Roche
Country: Canada
Dosage: 150 mg
Qty: 60
USD $209.00
Type: drug type
Product: Xeloda
Manufacturer: Hoffman - La Roche
Country: Canada
Dosage: 150 mg
Qty: 120
USD $379.00
Type: drug type
Product: Xeloda
Manufacturer: Hoffman - La Roche
Country: Canada
Dosage: 500 mg
Qty: 120
USD $955.00
Type: drug type
Product: Xeloda
Manufacturer: Roche Pharmaceuticals
Country: Australia
Dosage: 500 mg
Qty: 120
USD $499.00
Type: drug type
Product: Capecitabine
Manufacturer: Generic
Country: Canada
Dosage: 150 mg
Qty: 60
USD $110.00
Type: drug type
Product: Capecitabine
Manufacturer: Generic
Country: Canada
Dosage: 150 mg
Qty: 180
USD $310.00
Type: drug type
Product: Capecitabine
Manufacturer: Generic
Country: Canada
Dosage: 500 mg
Qty: 120
USD $675.00
Type: drug type
Product: Capecitabine (Caxeta - Sun Pharma)
Manufacturer: Generic
Country: India
Dosage: 500 mg
Qty: 120
USD $499.00

Xeloda online Canadian Pharmacy
Xeloda Information
Breast cancer treatment Xeloda (Capecitabine) is indicated as first-line treatment of patients with metastatic colorectal carcinoma when treatment with fluoropyrimidine therapy alone is preferred. Combination chemotherapy has shown a survival benefit compared to 5-FU/LV alone. A survival benefit over 5-FU/LV has not been demonstrated with Xeloda breast cancer treatment monotherapy. Use of Xeloda (Capecitabine) breast cancer treatment instead of 5-FU/LV in combinations has not been adequately studied to assure safety or preservation of the survival advantage. Xeloda (Capecitabine) in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline-containing chemotherapy. Xeloda (Capecitabine) monotherapy is also indicated for the treatment of patients with metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen or resistant to paclitaxel and for whom further anthracycline therapy is not indicated, eg, patients who have received cumulative doses of 400 mg/m2 of doxorubicin or doxorubicin equivalents. Resistance is defined as progressive disease while on treatment, with or without an initial response, or relapse within 6 months of completing treatment with an anthracycline-containing adjuvant regimen.

CanadaPharmacyOnline.com supplies only genuine Xeloda from Canada, Australia and Turkey shipped using Canadian, Australian and Turkish packaging. This Xeloda is manufactured by Gentech Inc., the worldwide manufacturer of Xeloda. This offer is neither endorsed nor authorized by Gentech Inc. (the United States and Canadian distributor of Xeloda). CanadaPharmacyOnline.com has no affiliation whatsoever with Gentech Inc.
The generic alternative is not manufactured by the company that makes the brand product.

The content on this page has been supplied to CanadaPharmacOnline by an independent third party contracted to provide information for our website. CanadaPharmacyOnline relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us. If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional. Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy. We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, and United Kingdom. The items in your order maybe shipped from any of the above jurisdictions. The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources. All prices are in US dollars.

Drug Categories

Top Products

Prescriptions Dispensed from Canada are Dispensed by: Candrug ID#18985 604-543-8711. Pharmacy Manager: Mohammed Hassan This pharmacy is duly licensed in the province of British Columbia, Canada by the College of Pharmacists of BC. If you have any questions or concerns you can contact the college at: 200-1765 West 8th Ave Vancouver, BC V6J 5C6 Canada. All prices are in US dollars.
© Copyright 2006 - 2018 Canada Pharmacy Online. All Rights Reserved.